Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month Low at $268.24

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) reached a new 52-week low during trading on Tuesday . The stock traded as low as $268.24 and last traded at $268.88, with a volume of 42 shares trading hands. The stock had previously closed at $283.45.

Bio-Rad Laboratories Trading Down 5.1 %

The company has a fifty day simple moving average of $281.80 and a 200-day simple moving average of $310.14. The stock has a market cap of $7.67 billion, a price-to-earnings ratio of -27.36 and a beta of 0.72. The company has a current ratio of 6.57, a quick ratio of 4.89 and a debt-to-equity ratio of 0.13.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $2.29 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 12.37% and a positive return on equity of 3.59%. The business had revenue of $610.82 million during the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.